Sulfate is required for detoxification of xenobiotics such as acetaminophen (APAP), a leading cause of liver failure in humans. The NaS1 sulfate transporter maintains blood sulfate levels sufficiently high for sulfonation reactions to work effectively for drug detoxification. In the present study, we identified two loss-of-function polymorphisms in the human NaS1 gene and showed the Nas1-null mouse to be hypersensitive to APAP hepatotoxicity. APAP treatment led to increased liver damage and decreased hepatic glutathione levels in the hyposulfatemic Nas1-null mice compared with that in normosulfatemic wild-type mice. Analysis of urinary APAP metabolites revealed a significantly lower ratio of APAP-sulfate to APAPglucuronide in the Nas1-null mice. These results suggest hyposulfatemia increases sensitivity to APAP-induced hepatotoxicity by decreasing the sulfonation capacity to metabolize APAP. In conclusion, the results of this study highlight the importance of plasma sulfate level as a key modulator of acetaminophen metabolism and suggest that individuals with reduced NaS1 sulfate transporter function would be more sensitive to hepatotoxic agents. A cetaminophen (APAP; N-acetyl-p-aminophenol)-induced liver disease is the leading cause of drug-related liver failure in humans. 1 High APAP doses cause: 1) rapid depletion of GSH, 2) saturation of the sulfonation and glucuronidation pathways, and 3) increased production (and longer half-life) of the toxic reactive intermediate, N-acetyl-p-benzoquinone imine (NAPQI), which consequently leads to cellular damage and death. 2 Liver injury associated with high doses of APAP shows a marked dose threshold because of the protective action of hepatic GSH. 3 A decreased capacity to metabolize APAP by sulfonation could put more pressure on the existing GSH pool and hence lower the APAP dose threshold for liver injury. Sulfate conjugation (sulfonation), a major step in the metabolism of APAP in humans, relies on the availability of inorganic sulfate (SO 4 2Ϫ ) and its universal sulfonate donor 3Ј-phosphoadenosine 5Ј-phosphosulfate (PAPS). 4 SO 4 2Ϫ is obtained directly from the diet and from the oxidation of sulfur containing amino acids, cysteine, and methionine. 4 Because of its hydrophilicity, SO 4 2Ϫ needs to enter cells via plasma membrane sulfate transporters. 4 We cloned a kidney sulfate transporter, NaS1, which is expressed on the brush border membrane of renal proximal tubular epithelial cells, where it is involved in the first step of SO 4 2Ϫ reabsorption. 5 Recently, we generated NaS1-null (Nas1 Ϫ/Ϫ ) mice, which have very low (Ϸ0.2 mmol/L) serum sulfate levels compared to those (Ϸ1 mmol/L) in wild-type (Nas1 ϩ/ϩ ) mice. 6 In this study, we identified two loss-of-function polymorphisms in the human NaS1 gene and characterized the Nas1 Ϫ/Ϫ mouse showing increased APAP hepatotoxicity, suggesting disturbed NaS1 function produces hyposulfatemia that leads to increased drug-induced liver damage. From the
Materials and Methods
Xenopus laevis